Action Plan for Stroke in Europe 2018–2030

Abstract

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg meetings, were convened to review the scientific evidence and the state of current services to identify priorities for research and development and to set targets for the development of stroke care for the decade to follow. Adhering to the same format, the European Stroke Organisation (ESO) prepared a European Stroke Action Plan (ESAP) for the years 2018 to 2030, in cooperation with the Stroke Alliance for Europe (SAFE). The ESAP included seven domains: primary prevention, organisation of stroke services, management of acute stroke, secondary prevention, rehabilitation, evaluation of stroke outcome and quality assessment and life after stroke. Research priorities for translational stroke research were also identified. Documents were prepared by a working group and were open to public comments. The final document was prepared after a workshop in Munich on 21–23 March 2018. Four overarching targets for 2030 were identified: (1) to reduce the absolute number of strokes in Europe by 10%, (2) to treat 90% or more of all patients with stroke in Europe in a dedicated stroke unit as the first level of care, (3) to have national plans for stroke encompassing the entire chain of care, (4) to fully implement national strategies for multisector public health interventions. Overall, 30 targets and 72 research priorities were identified for the seven domains. The ESAP provides a basic road map and sets targets for the implementation of evidence-based preventive actions and stroke services to 2030.

Investigating the transition to home experience for people with mild stroke: the mild stroke transitional experience in Australia

“…The current study solidifies this finding in the mild stroke population. Furthermore, it has been identified in younger people with stroke that there is a need for more focus on nonmedical needs and care to be provided long after discharge (Morris, 2011). The current study confirms this finding within the mild stroke population as it was clear that support was appreciated during the 6 months post-discharge, with the support provided being focused on the person's holistic needs rather than their specific medical needs.…”

Case management after acquired brain injury compared to care as usual: study protocol for a two-year pragmatic randomized controlled trial

“…It is essential that people with ABI are supported in learning how to live with ABI, within the individual context in terms of home, education, work, relationships, stage of life and personal goals [14]. Creating a continuous chain of support from hospital discharge onwards is high on the agenda of guidelines and action plans for different types of ABI [12][13][14][15].…”

“…The importance of supporting a changed life after ABI is increasingly recognized in clinical guidelines [12,13]. Since there are relatively few methodologically sound studies evaluating longer-term care, the Action Plan for Stroke in Europe and the World Stroke Organization state that the development and evaluation of a 'seamless, coordinated chain of support', which includes life after ABI, is a development and research priority [14,15].…”

“…Long-term follow-up did show a positive effect on social activities and depression in stroke in a nonrandomized trial [30] and short-term transitional care interventions also show promising results [31,32]. However, since learning how to live with ABI is a dynamic process with uctuating needs over the course of several years, three to six-month follow-up in the rst year and annual reviews hereafter are necessary [14]. A methodologically sound investigation of the feasibility and effects in terms of health and costs of such long-term support is called for [14,15].…”

“…However, since learning how to live with ABI is a dynamic process with uctuating needs over the course of several years, three to six-month follow-up in the rst year and annual reviews hereafter are necessary [14]. A methodologically sound investigation of the feasibility and effects in terms of health and costs of such long-term support is called for [14,15]. This article describes the study protocol for a pragmatic randomized controlled trial on long-term case management (18-24 months) for people with ABI and their family.…”